~~<i id='B3DFF856B5'><strike id='B3DFF856B5'><tt id='B3DFF856B5'><pre id='B3DFF856B5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：knowledge 2025-09-30 20:35:32 - browse：93475

Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Alzheimer's risk factor APOE4 may be a distinct form of the disease

hotspot

knowledge

Wikipedia

leisure time

hotspot

AdobeEvenamongapparentlyhealthychildren,Blackpatientsarealmostthreeandahalftimesmorelikelytodiewithi

WSS

As biotech industry slumps, bioscience job market is upside down

Researchers test human milk's ability to repair gut microbiome

As biotech industry slumps, bioscience job market is upside down

UnitedHealth’s Optum accused of antitrust violations in California

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Scientists uncover potential path to treating deadly childhood tumor

hotspot

explore

hotspot

Walensky prepares to leave CDC — and Congress — behind

Pediatric cancer treatments threatened by a new FDA policy

Drug repurposing or repositioning? The language matters

With clinical trial data readouts, here's how to spot spin

BioMarin wins approval for gene therapy to treat hemophilia A

Study: Black kids more likely to die after surgery than white kids

BioMarin wins approval for gene therapy to treat hemophilia A

BIO selects John Crowley as new CEO

Novavax promises a turnaround & Lilly roils the obesity market

First Opinion on colorectal cancer screening: letter and response

knowledge

What to do when lifesaving products contribute to climate change

BIO selects John Crowley as new CEO

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Harvard scientists, with Google, unveil the most detailed brain map ever

What to do when lifesaving products contribute to climate change

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Wikipedia

Wikipedia

leisure time

hotspot